• News
  • BioTech

Reno Contracting and San Diego lead biotech industry's growth

Related Special Reports

With more than 700 manufacturing, diagnostic and traditional biotech firms in San Diego County, this region has become one of the leading centers for the biotechnology industry. An integral part of that growth is San Diego's Reno Contracting, founded in 1993 by CEO Matt Reno. The general contractor has been a major contributor in San Diego's biotech, commercial and retail building growth. Walt Fegley, president of Reno Contracting, noted that his company has been at the forefront in biotech because "we have the preconstruction, technical and building experience to deliver complex projects on time and on budget."

Building national headquarters for biotech

Reno Contracting's ability to build value into each project is reflected in the Biosite (Nasdaq: BSTE) headquarters: a $70 million, four-building, 350,000-square-foot campus, giving the company more than adequate research, office, manufacturing and laboratory space. This building was chosen for a 2007 Tilt-Up Building Award from the American Concrete Institute. Reno was also recognized through an Award of Honor from the Associated Building and Contractors' San Diego Chapter.

Verenium's San Diego laboratories.

Other biotech facilities built by Reno Contracting include Verenium's (Nasdaq: VRNM) facility in San Diego. The project for Building I involved construction of a 75,520-square-foot, two-story building with 30,270 square feet of that space devoted to laboratory facilities.

"From inception to client move-in took us only seven and a half months," said Reno Contracting's Project Director of Field Operations Erik Kissner, who was the superintendent on the project. Following the completion of Verenium's Building I, Reno built a second: Building II is a two-story, 66,600-square-foot steel and concrete facility housing a 20,565-square-foot laboratory. Property developer Verenium's Patrick Simms noted, "With both projects, Reno's reputation as a quality builder who sets high standards was certainly apparent, and Verenium now has a complex of which it can be proud."

Micromet (Nasdaq: MITI), formerly Cancervax, a biotech company developing immunotherapeutic products for cancer treatment, chose Reno Contracting in 2001 to construct its 61,210 square-foot, two-story concrete tilt-up and steel headquarters and R&D laboratories. The laboratory build-out included specialized chemistry labs, a molecular biology lab, immuno and protein chemistry labs and cytometry research area.

2008: Continued growth for Reno

Burnham Institute, an internationally known research company, received a grant this year to expand its stem-cell research program and turned to Reno's experience in constructing complex, specialty labs. The new conversion split its existing space into two separate areas for research, development and equipment. Burnham Institute's head of facilities, David Hassell, explained why he puts his trust in Reno Contracting's abilities: "Customer satisfaction is Reno's strength and that's why I work with them. Their attention to detail and constant communication with me makes my life easier ... the project runs smoothly, thanks to Reno."

With a continuing expansion of the biotechnology industry, Reno Contracting, Southern California's premier general contractor since 1993, joins these innovative companies to create outstanding build-to-suit facilities and laboratories to accommodate their needs. Reno's customer dedication is reflected by maintaining strict budget controls and on-time project completion, thereby building value into every project.

Submitted by Reno Contracting

User Response
0 UserComments